A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

ISSN
07533322
Date Issued
2023
Author(s)
DOI
10.1016/j.biopha.2023.114272
Subjects

Pharmacology